IndraLab

Statements

Mutated TSC1 inhibits MTOR. 1 / 1

| 1

reach

"The inactive mutation of TSC1 or TSC2 is found in patients with LAM to activate the crucial mammalian target of rapamycin (mTOR) signaling pathway and result in enhanced cell proliferation and migration."

33072782

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Mutated TSC1 inhibits MTOR. 1 / 1

INDRA sources:

Databases

Reading